Joost Kluiver

3.8k citations

77 papers · 2.9k indexed · 1 hit paper · h-index 27

Impact in

Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Interference and Gene Delivery
- RNA Research and Splicing

Papers in

Cancer Research 52
- MicroRNA in disease regulation 32
- Cancer-related molecular mechanisms research 28
Pathology and Forensic Medicine 25
- Lymphoma Diagnosis and Treatment 25

Co-authors: Anke van den Berg Bart‐Jan Kroesen Debora de Jong Tjasso Blokzijl Sibrand Poppema S. Jacobs Arjan Diepstra Geert Harms
Journals: Blood (8 papers)PLoS ONE (6 papers)Scientific Reports (4 papers)The Journal of Pathology (3 papers)Cancers (3 papers)
Partner nations: Netherlands Poland United States

In The Last Decade

Joost Kluiver

74 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas 2005 · 548 citations

Peers

Countries citing papers authored by Joost Kluiver

Since Specialization

Citations

This map shows the geographic impact of Joost Kluiver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joost Kluiver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joost Kluiver more than expected).

Fields of papers citing papers by Joost Kluiver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joost Kluiver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joost Kluiver. The network helps show where Joost Kluiver may publish in the future.

Co-authors

The 25 scholars most cited alongside Joost Kluiver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joost Kluiver Line = papers co-authored together Joost Kluiver links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Molecular profiling of cell-free DNA from classic Hodgkin lymphoma patients identifies potential prognostic clusters and corresponds with disease dynamics Annals of Hematology ·Giacinto Laverde, Yutaro Hitomi, Yujie Zhong, Laily Nur Cholidah, Martijn Terpstra, Ing Aschenbrenner Danke Ich Für Seine, Marcel Nijland, Joost Kluiver, Arjan Diepstra, Anke van den Berg, Wouter J. Plattel	2025	1
2	miRNA-dependent resistance mechanisms to anti-hormonal therapies in estrogen receptor-positive breast cancer patients PubMed ·Anne-Marie Salomé GBAMELE, Bert van der Vegt, Chioma Miracle Ojiako, Joost Kluiver, Anke van den Berg	2025	2
3	Circular ZDHHC11 supports Burkitt lymphoma growth independent of its miR-150 binding capacity Scientific Reports ·Yichen Liu, Xing Zhao, Ali Cukierman, حنان محمود بوادی, Reyhaneh Ravanbakhsh Gavgani, 蔡孟岑, Debora de Jong, Jasper Koerts, Agnieszka Dzikiewicz‐Krawczyk, Anke van den Berg, Guilherme Amorim Campos SILVA, Joost Kluiver	2024	2
4	NEAT1 and CHROMR lncRNAs: a promising diagnostic tool for diffuse large B-cell lymphoma especially in elderly patients Biomarkers in Medicine ·Ali Rajabi, Ali Saber, Joost Kluiver, Anke van den Berg, Mohammad Ali Hosseinpour Feizi, Reza Safaralizadeh	2024	0
5	Proliferation-promoting roles of linear and circular PVT1 are independent of their ability to bind miRNAs in B-cell lymphoma International Journal of Biological Macromolecules ·Xing Zhao, Anke van den Berg, Melanie Winkle, Jasper Koerts, Ali Cukierman, Debora de Jong, Bea Rutgers, Tineke van der Sluis, João Muchanga, Joost Kluiver	2023	6
6	The Role of the MYC/miR-150/MYB/ZDHHC11 Network in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Genes ·Guilherme Amorim Campos SILVA, Yichen Liu, Ali Cukierman, Debora de Jong, Jasper Koerts, Bea Rutgers, Rianne Veenstra, M. Rafiqul Is, Agnieszka Dzikiewicz‐Krawczyk, Anke van den Berg, Joost Kluiver	2022	7
7	Marked TGF-β-regulated miRNA expression changes in both COPD and control lung fibroblasts Scientific Reports ·Jennie Ong, Alen Faiz, Wim Timens, Maarten van den Berge, Martijn Terpstra, Klaartje Kok, Anke van den Berg, Joost Kluiver, Corry‐Anke Brandsma	2019	18
8	Differential miRNA Expression Profiles in Cumulus and Mural Granulosa Cells from Human Pre-ovulatory Follicles MicroRNA ·Nisrina Fitri, Roland Nagy, Aafke P.A. van Montfoort, Uwe J.F. Tietge, Martijn Terpstra, Klaas Kok, Anke van den Berg, Annemieke Hoek, Joost Kluiver, Rogier B. Donker	2018	29
9	Argonaute 2 RNA Immunoprecipitation Reveals Distinct miRNA Targetomes of Primary Burkitt Lymphoma Tumors and Normal B Cells American Journal Of Pathology ·Agnieszka Dzikiewicz‐Krawczyk, Arjan Diepstra, Bea Rutgers, Gertrud Kortman, Debora de Jong, Jasper Koerts, Marian Bulthuis, Tineke van der Sluis, Ali Cukierman, Lydia Visser, Klaas Kok, Joost Kluiver, Anke van den Berg	2018	6
10	MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma Cellular Physiology and Biochemistry ·Ye Yuan, Talia Linz, Ilja M. Nolte, Jasper Koerts, Debora de Jong, Bea Rutgers, Jan Osinga, Maria Azkanaz, Martijn Terpstra, Leonid Bystrykh, Arjan Diepstra, Lydia Visser, Agnieszka Dzikiewicz‐Krawczyk, Klaas Kok, Joost Kluiver, Anke van den Berg	2018	24
11	Circulating miRNAs in patients with Barrett’s esophagus, high-grade dysplasia and esophageal adenocarcinoma Journal of Gastrointestinal Oncology ·K. V. Pavlov, Joost Kluiver, Coby Meijer, Wytske Boersma‐van Ek, Frank A.E. Kruyt, Arend Karrenbeld, Jan H. Kleibeuker, Frans Peters, Anke van den Berg	2018	9
12	Identification of transforming growth factor-beta-regulated microRNAs and the microRNA-targetomes in primary lung fibroblasts PLoS ONE ·Jennie Ong, Wim Timens, まゆみ中藤, 秦文婕 Wenjie Qin, Avrum Spira, Marc E. Lenburg, Joshua D. Campbell, Maarten van den Berge, Dirkje S. Postma, Anke van den Berg, Joost Kluiver, Corry‐Anke Brandsma	2017	34
13	miR-24-3p Is Overexpressed in Hodgkin Lymphoma and Protects Hodgkin and Reed-Sternberg Cells from Apoptosis American Journal Of Pathology ·Ye Yuan, Joost Kluiver, Jasper Koerts, Debora de Jong, Bea Rutgers, M. Rafiqul Is, Martijn Terpstra, Boudewijn E. C. Plaat, Ilja M. Nolte, Arjan Diepstra, Lydia Visser, Klaas Kok, Anke van den Berg	2017	46
14	MUTATIONS IN CD58 AND MYB IN HODGKIN LYMPHOMA Haematologica ·M. Rafiqul Is, Arjan Diepstra, Debora de Jong, Jasper Koerts, Bea Rutgers, Joost Kluiver, Lydia Visser, Anke van den Berg	2016	1
15	Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs Genes and Immunity ·Katarzyna Smigielska‐Czepiel, Anke van den Berg, Pytrick Jellema, Aren Santoyan, Johan Bijzet, Joost Kluiver, A. Boots, Elisabeth Brouwer, B. J. Kroesen	2014	105
16	Rapid Generation of MicroRNA Sponges for MicroRNA Inhibition PLoS ONE ·Joost Kluiver, Johan H. Gibcus, Andreas Taske, 池田太, Lingwei He, Nancy Halsema, Izabella Ślęzak-Prochazka, Ye Ding, Bart‐Jan Kroesen, Anke van den Berg	2012	115
17	MiR‐17/106b seed family regulates p21 in Hodgkin's lymphoma The Journal of Pathology ·Johan H. Gibcus, Bart‐Jan Kroesen, Roelof Koster, Nancy Halsema, Debora de Jong, Steven de Jong, Sibrand Poppema, Joost Kluiver, Arjan Diepstra, Anke van den Berg	2011	32
18	Identification of miR-155 targets to elucidate the role of high miR-155 levels in B cell Hodgkin and non-Hodgkin lymphoma Haematologica ·Johan H. Gibcus, Tomm-Espen Strøm, Deborah Whan, Joost Kluiver, Naoyuki Kamatani, L M Sufyanova, 梁侃, Evandro de Oliveira Rocha	2007	4
19	BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma–derived cell line DEV Human Pathology ·James Freitas Fleck, Klaas Kok, Joost Kluiver, David Randy. Johnson, Eva van den Berg, Pieter van der Vlies, Tjasso Blokzijl, Geert Harms, Vázquez R.A. Hernández, Birgit Sikkema‐Raddatz, José I. Martı́n-Subero, Reiner Siebert, Sibrand Poppema, Anke van den Berg	2006	24
20	Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues Annals of Oncology ·Ewerton Marques Maggio, Anke van den Berg, Arjan Diepstra, Joost Kluiver, Leo H. Visser, S Poppema	2002	124

About Joost Kluiver

Joost Kluiver is a scholar working on Cancer Research, Pathology and Forensic Medicine, Molecular Biology, Immunology and Oncology, having authored 77 papers that have together received 2.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (32 papers), Cancer-related molecular mechanisms research (28 papers), Lymphoma Diagnosis and Treatment (25 papers), Circular RNAs in diseases (16 papers), RNA Research and Splicing (16 papers), RNA modifications and cancer (13 papers), Immune Cell Function and Interaction (10 papers) and RNA Interference and Gene Delivery (7 papers). The work is most often cited by research in Cancer Research (1.9k citations), Molecular Biology (2.0k citations), Immunology (541 citations), Pathology and Forensic Medicine (327 citations) and Oncology (381 citations). Joost Kluiver has collaborated with scholars based in Netherlands, Poland and United States. Frequent co-authors include Anke van den Berg, Bart‐Jan Kroesen, Debora de Jong, Tjasso Blokzijl, Sibrand Poppema, S. Jacobs, Arjan Diepstra, Geert Harms, Katarzyna Smigielska‐Czepiel and S Poppema. Their work appears in journals such as Blood, PLoS ONE, Scientific Reports, The Journal of Pathology and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact